Use of sodium‐glucose co‐transporter‐2 inhibitors in <scp>Asian</scp> patients with type 2 diabetes and kidney disease: An <scp>Asian</scp> perspective and expert recommendations

Meng Khoo, Chin; Deerochanawong, Chaicharn; Pheng Chan, Siew; J. Matawaran, Bien; Huey‐Herng Sheu, Wayne; C.N. Chan, Juliana; Mithal, Ambrish; O. Y. Luk, Andrea; Suastika, Ketut; Yoon, Kun‐Ho; Ji, Linong; Huu Man, Nguyen; A. Pollock, Carol

doi:10.1111/dom.14251

Public

Use of sodium‐glucose co‐transporter‐2 inhibitors in <scp>Asian</scp> patients with type 2 diabetes and kidney disease: An <scp>Asian</scp> perspective and expert recommendations

Published in Diabetes Obesity and Metabolism • Nov 6, 2020

Authors:

Chin Meng Khoo

Chaicharn Deerochanawong

Siew Pheng Chan

Abstract

Early onset of type 2 diabetes and a high prevalence of co-morbidities predispose the Asian population to a high risk for, and rapid progression of, diabetic kidney disease (DKD). Apart from renin-angiotensin system inhibitors, sodium-glucose co-transporter-2 (SGLT-2) inhibitors have been shown to d...

View

Open Access

Subject

Medicine

Renal function

Diabetes mellitus

Generate AI Take for this paper

Highlights, strengths & weaknesses, commercial applications, and societal impact — written for this paper on demand.

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!